Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06730529

The Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases

Status
Recruiting
Phase
Study type
Observational
Enrollment
40 (estimated)
Sponsor
Ruijin Hospital · Academic / Other
Sex
All
Age
16 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to investigate the value of 68Ga-FAPI in the preoperative evaluation of thyroid cancer of different pathologic types.

Detailed description

The investigators will number all participants, create a medical record file, and record their basic information (gender, age) as well as contact information and medical history information. All participants will undergo a 68Ga-FAPI PET/CT before surgery. The imaging response measurements will be compared with the histopathological results as gold standard.

Conditions

Timeline

Start date
2024-11-29
Primary completion
2029-12-31
Completion
2029-12-31
First posted
2024-12-12
Last updated
2024-12-12

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06730529. Inclusion in this directory is not an endorsement.